Global & Disaster Medicine

Archive for the ‘Botulism’ Category

Emergent Biosolutions gets Health Canada approval for Botulism antitoxin


Emergent BioSolutions Inc.  today announced that Health Canada has approved the company’s New Drug Submission (NDS) for its botulism antitoxin, BAT® [Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) – (Equine)]. BAT is indicated for the treatment of symptomatic botulism following documented or suspected exposure to botulinum neurotoxin serotypes A, B, C, D, E, F, or G in adults and pediatric patients…….

Emergent has an existing ten-year contract, executed in 2012, to supply BAT to the Canadian Department of National Defense as well as the Public Health Agency of Canada and individual provincial health authorities. In addition, Emergent has been supplying BAT to the U.S. Strategic National Stockpile as part of a $450 million contract with the Biomedical Advanced Research and Development Authority (BARDA), within the Office of the Assistant Secretary for Preparedness and Response in the U.S. Department of Health and Human Services. BAT, which was licensed by the U.S. Food and Drug Administration in 2013, is the only botulism antitoxin available in the U.S. for treating naturally occurring, non-infant botulism, and for administering to patients under emergency conditions…..”


Mangia olive al botulino e finisce in coma, poi viene dimessa in anticipo dall’ospedale e muore per complicanze.

Il Messagero


 clostridium botulinum


Taiwan: 9th case of suspected iatrogenic botulism


	clostridium botulinum

China: Four cases of botox-related botulism

South China Morning Post

“…The four women, aged between 21 and 47, developed potentially fatal complications such as difficulty in swallowing and breathing, and were admitted into hospitals for further treatment…..”



Recent Posts